aspect of
thc)
→
AtLocation
→
clinical setting
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| during a human trial phase | 3 | temporal |
| effect → be in → clinical setting | 3 |
| negative | neutral | positive |
| 0.265 | 0.702 | 0.033 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 65.483 |